WP Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-13,446
Closed -$1.03M 79
2020
Q2
$1.03M Sell
13,446
-4,146
-24% -$318K 0.73% 25
2020
Q1
$1.31M Sell
17,592
-3,957
-18% -$273K 1.28% 14
2019
Q4
$1.4M Sell
21,549
-2,300
-10% -$150K 1.45% 16
2019
Q3
$1.51M Sell
23,849
-3,094
-11% -$202K 1.73% 17
2019
Q2
$1.82M Sell
26,943
-1,243
-4% -$81.8K 2.03% 17
2019
Q1
$18.3K Buy
28,186
+2
+0% +$133 1.99% 15
2018
Q4
$1.76M Sell
28,184
-179
-0.6% -$12.5K 1.74% 21
2018
Q3
$2.19M Sell
28,363
-944
-3% -$71.3K 2.04% 14
2018
Q2
$2.08M Buy
29,307
+519
+2% +$36.6K 1.96% 15
2018
Q1
$2.17M Sell
28,788
-1,423
-5% -$113K 2.34% 13
2017
Q4
$2.16M Sell
30,211
-928
-3% -$70.5K 2.1% 17
2017
Q3
$2.52M Sell
31,139
-184
-0.6% -$14.1K 1.91% 16
2017
Q2
$2.22M Sell
31,323
-3,544
-10% -$236K 1.61% 20
2017
Q1
$2.37M Buy
34,867
+2,368
+7% +$167K 1.49% 18
2016
Q4
$2.33M Buy
+32,499
New +$2.42M 1.62% 18

Other funds holding GILD

WP Advisors's GILD Position: Q3 2020 in Review

WP Advisors sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 13,446 shares — an estimated $1.03M sold.

WP Advisors first reported a position in GILD in Q4 2016 and held it in 15 quarters. The position peaked at $2.52M in Q3 2017. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • WP Advisors reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • WP Advisors sold 13,446 Gilead Sciences shares in Q3 2020, an estimated $1.03M.
  • WP Advisors first reported a position in Gilead Sciences in Q4 2016 and held it in 15 quarters.
  • WP Advisors's Gilead Sciences position peaked at $2.52M in Q3 2017.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on WP Advisors's 13F filing for Q3 2020, filed 16 Oct 2020.